This site is intended for Healthcare Professionals only.

Tag: BBA

spot_imgspot_img

‘Use of biosimilar medicines to treat moderate arthritis is hugely significant milestone’

The National Institute for Health and Care Excellence (NICE)'s decision to recommend the use of biosimilar medicines to treat moderate rheumatoid arthritis is a...

Teva’s Andrew Ellis is new BBA chair

The British Biosimilars Association (BBA), the representative group of biosimilar manufacturers in the UK, today named Teva's Dr Andrew Ellis as its new chair. He replaces...